Crossref
2.人工核酸を用いた遺伝子標的核酸医薬の開発
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 2026 · 57 (3) · 37-40
DOI: 10.3999/jscpt.57.3_37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2026. Verfasst von 陽祐 谷口.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
谷口, 陽. (2026). 2.人工核酸を用いた遺伝子標的核酸医薬の開発. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 57(3), 37-40. https://doi.org/10.3999/jscpt.57.3_37
Vancouver
谷口 陽. 2.人工核酸を用いた遺伝子標的核酸医薬の開発. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2026;57(3):37-40. doi:10.3999/jscpt.57.3_37
BibTeX
@article{2026,
author = {谷口, 陽祐},
title = {2.人工核酸を用いた遺伝子標的核酸医薬の開発},
journal = {Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {57},
number = {3},
pages = {37--40},
doi = {10.3999/jscpt.57.3_37}
}
EUVIMED